Sign in
4

Changes in Ownership

Cullinan Therapeutics, Inc. Filed Acc 0000899243-21-040774

Options or other derivatives

  • President and CEO acquired 2,710,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
AHMED NADIM President and CEO 2021-10-18 Grant or award · Stock Option (Right to Buy) +2,710,000 2,710,000 D: show line 1 in the form
Loading xslF345X03/doc4.xml…